Shizuru Judith Anne

Shizuru Judith Anne, Director, has filed 1 SEC report (2025), all concentrated in Jasper Therapeutics, Inc. (JSPR), totaling $219.3K in disclosed volume. Weighing $99.6K bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $99.6K in Jasper Therapeutics, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.